Canada markets closed

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
16.48-0.94 (-5.40%)
At close: 04:00PM EDT
16.60 +0.12 (+0.73%)
After hours: 07:18PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
289,333
233,662
2,785
6,689
152
Cost of Revenue
18,715
14,131
265
790
0
Gross Profit
270,618
219,531
2,520
5,899
152
Operating Expenses
Research Development
93,044
76,192
125,352
222,579
165,896
Selling General and Administrative
129,219
122,706
70,007
128,090
107,850
Total Operating Expenses
222,263
198,898
195,359
350,669
273,746
Operating Income or Loss
48,355
20,633
-192,839
-344,770
-273,594
Interest Expense
12,059
12,615
10,191
5,638
6,329
Total Other Income/Expenses Net
5,320
5,044
4,695
2,307
542
Income Before Tax
41,616
13,062
-198,335
-348,101
-279,381
Income Tax Expense
419
390
0
0
-
Income from Continuing Operations
41,197
12,672
-198,335
-348,101
-279,381
Net Income
41,197
12,672
-198,335
-348,101
-279,381
Net Income available to common shareholders
41,197
12,672
-198,335
-348,101
-279,381
Basic EPS
-1.46
0.09
-1.46
-2.63
-2.42
Diluted EPS
-1.46
0.09
-1.46
-2.63
-2.42
Basic Average Shares
135,411
141,955
135,411
132,223
115,334
Diluted Average Shares
135,411
148,508
135,411
132,223
115,334